carbohydrazide has been researched along with Muscular Dystrophy, Duchenne in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bazan, NA; Chatzopoulou, M; Conole, D; Davies, KE; Davies, SG; Donald, JR; Edwards, B; Fairclough, RJ; MartÃnez, RF; Milner, JA; Russell, AJ; Shah, N; Squire, SE; Vuorinen, A; Wilkinson, IVL; Willis, NJ; Wilson, FX; Wynne, GM | 1 |
1 other study(ies) available for carbohydrazide and Muscular Dystrophy, Duchenne
Article | Year |
---|---|
Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy.
Topics: Dose-Response Relationship, Drug; Drug Discovery; Humans; Hydrazines; Molecular Structure; Muscular Dystrophy, Duchenne; Pyrimidines; RNA, Messenger; Structure-Activity Relationship; Utrophin | 2021 |